ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVGN Avigen (MM)

1.32
0.00 (0.00%)
18 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Avigen (MM) NASDAQ:AVGN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.32 0 01:00:00

- Current report filing (8-K)

11/08/2009 8:56pm

Edgar (US Regulatory)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_______________

FORM 8-K

      CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 10, 2009

AVIGEN, INC.
(Exact name of registrant as specified in charter)

Delaware 000-28272 13-3647113
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer Identification
incorporation)   No.)

1301 Harbor Bay Parkway
Alameda, California 94502
(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (510) 748-7150

_____________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02. Results of Operations and Financial Condition.

     On August 10, 2009 , Avigen, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2009 . A copy of the press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.

     The information in this Section 2.02 and in the press release attached as Exhibit 99.1 to this current report, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Section 2.02 and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Avigen, Inc., whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

      Exhibit          
  Number                     Description  
99.1     Press Release, dated August 10, 2009 , announcing Avigen’s financial results for the quarter ended June 30, 2009 .  


SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

  A VIGEN, I NC .  
 
 
Dated: August 11, 2009   By:      /s/ A NDREW A. S AUTER  
    Andrew A. Sauter  
    Chief Executive Officer, President and  
    Chief Financial Officer  


INDEX TO EXHIBITS

      Exhibit          
  Number                     Description  
99.1     Press Release, dated August 10 , 2009, announcing Avigen’s financial results for the quarter ended June 30, 2009 .  


1 Year Avigen (MM) Chart

1 Year Avigen (MM) Chart

1 Month Avigen (MM) Chart

1 Month Avigen (MM) Chart